Cargando…

Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes

BACKGROUND: Thyroid nodules with atypia of undetermined significance (AUS) on fine‐needle aspiration (FNA) have a low risk of malignancy that appears to vary based on specific features described in the AUS diagnosis. The Afirma gene expression classifier (GEC) is a molecular test designed to improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baca, Sylvan C., Wong, Kristine S., Strickland, Kyle C., Heller, Howard T., Kim, Matthew I., Barletta, Justine A., Cibas, Edmund S., Krane, Jeffrey F., Marqusee, Ellen, Angell, Trevor E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484344/ https://www.ncbi.nlm.nih.gov/pubmed/28152275 http://dx.doi.org/10.1002/cncy.21827

Ejemplares similares

The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision‐making from a fine‐needle aspiration sample
por: Krane, Jeffrey F., et al.
Publicado: (2020)

Performance of Afirma genomic sequencing classifier and histopathological outcome are associated with patterns of atypia in Bethesda category III thyroid nodules
por: Jin, Xiaobing, et al.
Publicado: (2022)

Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules
por: Hao, Yangyang, et al.
Publicado: (2019)

The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer
por: Silva de Morais, Nathalie, et al.
Publicado: (2019)

Shear wave elastography and Afirma™ gene expression classifier in thyroid nodules with indeterminate cytology: a comparison study
por: Azizi, Ghobad, et al.
Publicado: (2018)

MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier
por: Polavarapu, Preethi, et al.
Publicado: (2020)

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021)

The variable phenotype and low-risk nature of RAS-positive thyroid nodules
por: Medici, Marco, et al.
Publicado: (2015)

Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules
por: Hu, Mimi I, et al.
Publicado: (2021)

The Diagnostic Performance of Afirma Gene Expression Classifier for the Indeterminate Thyroid Nodules: A Meta-Analysis
por: Liu, Ying, et al.
Publicado: (2019)

Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)—A Meta-analysis
por: Nasr, Christian E, et al.
Publicado: (2022)

Prevalence of cancer and the benign call rate of afirma gene classifier in (18)F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules
por: Endo, Mayumi, et al.
Publicado: (2021)

Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making
por: Kloos, Richard T.
Publicado: (2017)

LBSAT255 Real World Performance Of The Afirma Genomic Sequencing Classifier (GSC) - A Meta-analysis
por: Nasr, Christian E, et al.
Publicado: (2022)

The first Canadian experience with the Afirma® gene expression classifier test
por: Kay-Rivest, Emily, et al.
Publicado: (2017)

Use of the Afirma® Gene Expression Classifier for Preoperative Identification of Benign Thyroid Nodules with Indeterminate Fine Needle Aspiration Cytopathology
por: Ali, Syed Z., et al.
Publicado: (2013)

Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study
por: Medici, Marco, et al.
Publicado: (2016)

Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier
por: Randolph, Gregory W., et al.
Publicado: (2022)

Acto que afirma
por: Meléndez, Juana
Publicado: (1976)

Endometriosis mimicking glandular atypia in a cervical cytology
por: Rodriguez–Urrego, Paula A, et al.
Publicado: (2017)

Cutaneous epithelioid angiomatous nodule: a report of a series including a case with moderate cytologic atypia and immunosuppression
por: Chetty, Runjan, et al.
Publicado: (2018)

Diagnosing thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology with the deep convolutional neural network
por: Youn, Inyoung, et al.
Publicado: (2021)

The Limitations of Exfoliative Cytology for the Detection of Epithelial Atypia in Oral Leukoplakias
por: Dabelsteen, E., et al.
Publicado: (1971)

Hyaline Cell-Rich Apocrine Mixed Tumor with Cytologic Atypia
por: Ohata, Chika
Publicado: (2018)

Quantifying the Hidden Impact of the COVID-19 Pandemic: The Cytology Perspective
por: Yousefi, Elham, et al.
Publicado: (2021)

Liquid-Based Cytology in the Detection of Premalignant Lesions in Patients with “Atypia in Squamous Cells” in Conventional Cytology
por: Barrios, Lia, et al.
Publicado: (2022)

THU222 Malignancy Risk In Nodules Classified As Atypia Of Undetermined Significance In A Predominantly Hispanic Free-standing Children’s Hospital
por: Baboun, Daniela, et al.
Publicado: (2023)

Detection and Outcome of Endocervical Atypia in Cytology in Primary HPV Screening Programme
por: Pulkkinen, Johanna, et al.
Publicado: (2021)

MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier
por: Waguespack, Steven, et al.
Publicado: (2019)

THU678 Real-world Performance Of Afirma Genomic Sequencing Classifier (GSC) In A Community Healthcare Setting
por: Master, Vidisha, et al.
Publicado: (2023)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study †
por: Kandil, Emad, et al.
Publicado: (2023)

Malignancy Rate in Thyroid Nodules with Atypia or Follicular Lesion of Undetermined Significance
por: Pasha, Hamdan Ahmed, et al.
Publicado: (2020)

Evaluation of selected ultrasound features of thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance for the Bethesda reporting system for thyroid cytology
por: Kaliszewski, Krzysztof, et al.
Publicado: (2018)

Fine needle aspiration cytology finding of a parotid mass with chondromyxoid matrix and variable epithelial cytological atypia
por: Kim, Hyun-Jung
Publicado: (2018)

Effective Use of microRNA, BRAF and Sonographic Risk Assessment in Bethesda III Thyroid Nodules Requires a Different Approach to Nodules with Features of Nuclear Atypia and Other Types of Atypia
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2023)

MON-525 ATA and ACR TIRADS Classification Systems as Additional Predictors of Malignancy in Afirma GSC Suspicious Thyroid Nodules
por: Azaryan, Irina, et al.
Publicado: (2020)

Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3
por: Kim, Na Eun, et al.
Publicado: (2023)

Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology
por: Skaugen, John M., et al.
Publicado: (2022)

Increased Cancer Risk in Younger Patients with Thyroid Nodules Diagnosed as Atypia of Undetermined Significance
por: Todorovic, Emilija, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c0hhhion3bcsoqjj5n4d3di7vm